Literature DB >> 16952971

Antithrombotic treatment in atrial fibrillation.

L Kalra1, G Y H Lip.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952971      PMCID: PMC1861321          DOI: 10.1136/hrt.2006.099911

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  49 in total

1.  A differential effect of aspirin on prevention of stroke in atrial fibrillation.

Authors: 
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-06-09       Impact factor: 2.136

2.  Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.

Authors:  Gregory Y H Lip; Deirdre Lane; Carl Van Walraven; Robert G Hart
Journal:  Stroke       Date:  2006-08-03       Impact factor: 7.914

3.  Is warfarin really underused in patients with atrial fibrillation?

Authors:  S D Weisbord; J Whittle; R C Brooks
Journal:  J Gen Intern Med       Date:  2001-11       Impact factor: 5.128

4.  Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness.

Authors:  L Kalra; G Yu; I Perez; A Lakhani; N Donaldson
Journal:  BMJ       Date:  2000-05-06

5.  Warfarin use among patients with atrial fibrillation.

Authors:  L M Brass; H M Krumholz; J M Scinto; M Radford
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

6.  Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.

Authors:  A Howitt; D Armstrong
Journal:  BMJ       Date:  1999-05-15

7.  Use of antithrombotic measures for stroke prevention in atrial fibrillation.

Authors:  I Perez; A Melbourn; L Kalra
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

8.  Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation.

Authors:  M F Stoddard; P R Dawkins; C R Prince; R A Longaker
Journal:  Am Heart J       Date:  1995-06       Impact factor: 4.749

9.  Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Authors:  E M Hylek; D E Singer
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983

View more
  6 in total

Review 1.  Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.

Authors:  Adedotun A Ogunsua; Amir Y Shaikh; Mohamed Ahmed; David D McManus
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

Review 2.  Stroke prevention in the high-risk atrial fibrillation patient: Medical management.

Authors:  Michael Broukhim; Jonathan L Halperin
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

3.  Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.

Authors:  Michelle D Schmiegelow; Ole D Pedersen; Lars Køber; Marie Seibæk; Steen Z Abildstrøm; Christian Torp-Pedersen
Journal:  BMC Cardiovasc Disord       Date:  2011-05-14       Impact factor: 2.298

4.  Antithrombotic medication for cardioembolic stroke prevention.

Authors:  M Àngels Font; Jerzy Krupinski; Adrià Arboix
Journal:  Stroke Res Treat       Date:  2011-06-22

5.  Clinical use of aspirin in treatment and prevention of cardiovascular disease.

Authors:  Yuxiang Dai; Junbo Ge
Journal:  Thrombosis       Date:  2011-11-24

6.  Analysis of antithrombotic therapy after cardioembolic stroke due to atrial fibrillation or flutter.

Authors:  Evan J Peterson; Anne B Reaves; Jennifer L Smith; Carrie S Oliphant
Journal:  Hosp Pharm       Date:  2013-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.